OBJECTIVES: Small studies of extracorporeal membrane oxygenation (ECMO) support for children with refractory septic shock (RSS) suggest that high-flow (≥ 150 mL/kg/min) venoarterial ECMO and a central cannulation strategy may be associated with lower odds of mortality. We therefore aimed to examine a large, international dataset of venoarterial ECMO patients for pediatric sepsis to identify outcomes associated with flow and cannulation site. DESIGN: Retrospective analysis of the Extracorporeal Life Support Organization (ELSO) database from January 1, 2000, to December 31, 2021. SETTING: International pediatric ECMO centers. PATIENTS: Patients 18 years old young or younger without congenital heart disease (CHD) cannulated to venoarterial ECMO primarily for a diagnosis of sepsis, septicemia, or septic shock. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Of 1242 pediatric patients undergoing venoarterial ECMO runs in the ELSO dataset, overall mortality was 55.6%. We used multivariable logistic regression analyses to evaluate explanatory factors associated with adjusted odds ratios (aORs) and 95% CI of mortality. In the regression analysis of data 4 hours after ECMO initiation, logarithm of the aOR, plotted against ECMO flow as a continuous variable, showed that higher flow was associated with lower aOR of mortality (p = 0.03). However, at 24 hours, we failed to find such a relationship. Finally, peripheral cannulation, as opposed to central cannulation, was independently associated with greater odds of mortality (odds ratio, 1.7 [95% CI, 1.1–2.6]). CONCLUSIONS: In this 2000–2021 international cohort of venoarterial ECMO for non-CHD children with sepsis, we have found that higher ECMO flow at 4 hours after support initiation, and central- rather than peripheral-cannulation, were both independently associated with lower odds of mortality. Therefore, flow early in the ECMO run and cannula location are two important factors to consider in future research in pediatric patients requiring cannulation to venoarterial ECMO for RSS.
Thrombocytopenia frequently occurs in patients before, during, and after admission to Pediatric Intensive Care Units (PICUs). In critically ill children, it is often due to multifactorial causes and can be a sign of significant organ dysfunction. This review summarizes the potential causes/mechanisms of thrombocytopenia in acutely ill children, their identification, and treatments, with special attention paid to septic patients. The mechanisms of thrombocytopenia include decreased production and sequestration, but the most common reason is increased destruction or consumption. This review specifically reviews and compares the presentation, pathogenesis, and treatment of disseminated intravascular coagulation (DIC) and the thrombotic microangiopathic spectrum (TMA), including thrombocytopenia-associated multiorgan failure (TAMOF), hemolytic uremic syndrome, and other diagnoses. The other etiologies discussed include HLH/MAS, immune thrombocytopenia, and dilutional thrombocytopenia. Finally, this review analyzes platelet transfusions, the various thresholds, and complications.
Objective: To evaluate the response of various oxygenation indices to the oxygen challenge test (OCT), prior to decannulation, in neonates supported with VA ECMO for respiratory indications, and to compare these responses between survivors and non-survivors. Design: Single-center retrospective observational study. Setting: Single, tertiary care, 40-bed Pediatric Intensive Care Unit in Miami, Florida. Patients: Neonates cannulated to VA ECMO for respiratory failure from 2012 to 2022 who had an OCT. Patients with congenital heart disease were excluded. Measurements and Main Results: A total of 63 neonates were included, of whom 13 patients died (20.6%). Oxygenation indices compared before and during OCT include PaO2, Delta PaO2, P/F ratios, Alveolar-arterial gradient, arterial/alveolar ratios, and shunt fraction. The Wilcoxon signed-rank test demonstrated increases in all oxygenation indices during OCT compared to pre-OCT, except for P/F ratios. There were no differences in oxygenation indices between survivors and non-survivors during OCT. However, after decannulation, all oxygenation indices were worse in non-survivors (p < 0.05). Linear regression analysis demonstrated that delta FiO2 on the ventilator, P/F before OCT, and ECMO flow during OCT significantly affected PaO2 response during OCT. Shunt fraction above 28.8% after decannulation demonstrated the highest discriminatory ability for mortality (AUC 0.853). Conclusions: The OCT response during ECMO is not a reliable predictor of survival in neonates on VA ECMO, and its value in assessing readiness for ECMO trial-off warrants further evaluation. Further studies investigating the role of oxygenation indices at the time of trial-off for predicting outcomes may be helpful.